依诺肝素与阿司匹林用于癌症合并缺血性脑卒中患者的疗效比较：TEACH 试验 Pilot 随机临床研究
Enoxaparin vs Aspirin in Patients With Cancer and Ischemic Stroke: The TEACH Pilot Randomized Clinical Trial.
机构信息
Department of Neurology, Weill Cornell Medicine, New York, New York.
Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York.
出版信息
JAMA Neurol. 2018 Mar 1;75(3):379-381. doi: 10.1001/jamaneurol.2017.4211.
Abstract
This randomized clinical trial compares anticoagulation vs antiplatelet therapy in patients with cancer and acute ischemic stroke.
摘要
这项随机临床试验比较了癌症合并急性缺血性卒中患者的抗凝治疗与抗血小板治疗。
相似文献
1
Enoxaparin vs Aspirin in Patients With Cancer and Ischemic Stroke: The TEACH Pilot Randomized Clinical Trial.
JAMA Neurol. 2018 Mar 1;75(3):379-381. doi: 10.1001/jamaneurol.2017.4211.
2
3
Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial.
JAMA. 2018 Jul 10;320(2):156-166. doi: 10.1001/jama.2018.8496.
4
FPIN's clinical inquiries. Aspirin in patients with acute ischemic stroke.
Am Fam Physician. 2009 Feb 1;79(3):226-7.
5
Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin.
Am Heart J. 2002 Sep;144(3):470-7. doi: 10.1067/mhj.2002.126115.
6
Low-molecular-weight heparin is more effective than aspirin in preventing early neurologic deterioration and improving six-month outcome.
J Stroke Cerebrovasc Dis. 2014 Jul;23(6):1537-44. doi: 10.1016/j.jstrokecerebrovasdis.2013.12.036. Epub 2014 Mar 19.
7
A pilot retrospective comparison of fondaparinux and enoxaparin for the prevention of venous thromboembolism (VTE) in patients with stroke.
Med Health R I. 2010 Nov;93(11):349-53.
8
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial.
JAMA. 2004 Jul 7;292(1):55-64. doi: 10.1001/jama.292.1.55.
9
Rationale and design of the PreventIon of CArdiovascular events in iSchemic Stroke patients with high risk of cerebral hemOrrhage (PICASSO) study: A randomized controlled trial.
Int J Stroke. 2015 Oct;10(7):1153-8. doi: 10.1111/ijs.12519. Epub 2015 Jun 4.
10
Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial.
Thromb Haemost. 2011 Feb;105(2):295-301. doi: 10.1160/TH10-05-0334. Epub 2010 Nov 23.
引用本文的文献
1
Intravenous thrombolysis in the context of stroke and cancer.
J Thromb Thrombolysis. 2025 Jul 17. doi: 10.1007/s11239-025-03156-5.
2
Cerebrovascular and Peripheral Vascular Complications in Cancer Patients.
Curr Neurol Neurosci Rep. 2025 Jul 1;25(1):46. doi: 10.1007/s11910-025-01434-6.
3
Cryptogenic embolic stroke and cancer.
Front Neurol. 2025 Jun 13;16:1537779. doi: 10.3389/fneur.2025.1537779. eCollection 2025.
4
Antithrombotic therapy for secondary stroke prevention in patients with cancer: a systematic review and network meta-analysis.
Eur J Clin Pharmacol. 2025 May 7. doi: 10.1007/s00228-025-03847-1.
5
Aspirin in Cancer Therapy: Pharmacology and Nanotechnology Advances.
Int J Nanomedicine. 2025 Feb 23;20:2327-2365. doi: 10.2147/IJN.S505636. eCollection 2025.
6
Epidemiology, Pathophysiology, and Management of Cancer-Associated Ischemic Stroke.
Cancers (Basel). 2024 Nov 29;16(23):4016. doi: 10.3390/cancers16234016.
7
Direct Oral Anticoagulants vs. Heparin for Cancer-Related Stroke: Augmented Meta-Analysis.
medRxiv. 2024 Nov 15:2024.11.14.24317340. doi: 10.1101/2024.11.14.24317340.
8
Cancer-Associated Stroke: Thrombosis Mechanism, Diagnosis, Outcome, and Therapeutic Strategies.
J Stroke. 2024 May;26(2):164-178. doi: 10.5853/jos.2023.03279. Epub 2024 May 30.
9
Malignancy-associated ischemic stroke: Implications for diagnostic and therapeutic workup.
CNS Neurosci Ther. 2024 Mar;30(3):e14619. doi: 10.1111/cns.14619.
10
Clinical analysis of twenty-one cases of acute ischemic stroke related to Trousseau syndrome.
Neurol Sci. 2024 Apr;45(4):1537-1547. doi: 10.1007/s10072-023-07180-2. Epub 2023 Nov 13.
本文引用的文献
1
Association between incident cancer and subsequent stroke.
Ann Neurol. 2015 Feb;77(2):291-300. doi: 10.1002/ana.24325. Epub 2015 Jan 7.
2
Direct oral anticoagulants in patients with VTE and cancer: a systematic review and meta-analysis.
Chest. 2015 Feb;147(2):475-483. doi: 10.1378/chest.14-0402.
3
Screen failure data in clinical trials: Are screening logs worth it?
Clin Trials. 2014 Aug;11(4):467-472. doi: 10.1177/1740774514538706. Epub 2014 Jun 12.
4
Recurrent thromboembolic events after ischemic stroke in patients with cancer.
Neurology. 2014 Jul 1;83(1):26-33. doi: 10.1212/WNL.0000000000000539. Epub 2014 May 21.
5
Stroke and cancer: the importance of cancer-associated hypercoagulation as a possible stroke etiology.
Stroke. 2012 Nov;43(11):3029-34. doi: 10.1161/STROKEAHA.112.658625. Epub 2012 Sep 20.
6
Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.
N Engl J Med. 2005 Mar 31;352(13):1305-16. doi: 10.1056/NEJMoa043033.
Zotero 插件